Emerging data suggest this peptide, a dual stimulator targeting both incretin and another hormone, may provide a promising development for weight loss . Preliminary clinical investigations have indicated substantial decreases in body mass , potentially exceeding current obesity medications . However , additional assessment is necessary to thoroughl